Quantcast

Latest hepatitis C Stories

2014-07-15 12:28:37

Unprecedented Growth Will be Fuelled by Rapid Uptake of All-Oral, Interferon-Free Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., July 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the hepatitis C virus (HCV) population is large with more than 2 million diagnosed, chronically infected cases throughout the G7 markets (United States, France, Germany, Italy, Spain, United Kingdom and Japan). Many of these patients, including more than 270,000 with...

2014-07-14 23:08:09

Hepatitis C is a contagious liver disease which results from infection with the Hepatitis C virus (HCV), which is spread primarily through contact with the blood of an infected person. The Life, Earth & Health Sciences Magazine EurekaMag.com has newly published abstracts of 64,900 studies of how this disease is transmitted and how such infection can be prevented. Mannheim, Germany (PRWEB) July 14, 2014 EurekaMag.com has newly published results of 64,900 studies on Hepatitis C which is...

2014-07-09 23:00:57

July 28th is designated as World Hepatitis Day by the World Health Organization, and Narconon Arrowhead is releasing information on hepatitis prevention to help raise awareness of viral hepatitis, and the need for better prevention programs. Canadian, Oklahoma (PRWEB) July 09, 2014 Narconon Arrowhead, the Oklahoma-based successful alcohol & drug rehabilitation center, will be releasing information on hepatitis and its prevention in support of World Hepatitis Day. Viral hepatitis is...

2014-07-03 10:47:18

University of Pennsylvania School of Medicine Less than 10 percent of people infected with hepatitis C are cured A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new,...

2014-07-01 12:27:54

- Results Confirm Efficacy and Safety of an All-Oral combination of Mogrovir(TM) with Ribavirin(TM) in Genotype 1, Therapy Naive HCV Patients. LOS ANGELES, July 1, 2014 /PRNewswire/ -- Canopus BioPharma Inc. (OTC Pink: CBIA) today announced topline results from a Compassionate Clinical Trial in China, evaluating the twice daily oral administration of Mogroside IV (Mogrovir(TM)). Mogrovir(TM) is a Toll-like receptor agonist and stimulator of the patient's immune system. Mogrovir(TM)...

2014-06-25 08:32:54

MILFORD, Mass., June 25, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability, and repeatability across the IVD lifecycle, today announced four new research panels that deliver hard-to-find material for Hepatitis C (HCV), Chagas and Dengue. http://photos.prnewswire.com/prnvar/20140625/121455 "Our customers rely on SeraCare to provide the disease materials they need to troubleshoot,...

2014-06-24 12:27:31

ST. LOUIS, June 24, 2014 /PRNewswire/ -- Accredo Specialty Pharmacy has recently launched Accredo Plus C, a new iOS app that empowers hepatitis C patients to take control, better manage their treatment and increase adherence. (Logo - http://photos.prnewswire.com/prnh/20140623/120692) Accredo Plus C is a free iPhone app available to all hepatitis C patients, regardless of pharmacy or insurance provider. The app was created by pharmacists and nurses that specialize in counseling hepatitis C...

2014-06-24 08:25:25

BEERSE, Belgium, June 24, 2014 /PRNewswire/ -- New report calls on governments to play their part and improve surveillance, screening and diagnosis of hepatitis C worldwide 'Tackling hepatitis C: Moving towards an integrated policy approach', a report published by The Economist Intelligence Unit (EIU) today reveals that many countries around the world have been slow to respond with national policies on hepatitis C despite recent government...

Hepatitis C treatment debate
2014-06-23 05:10:27

redOrbit Staff & Wire Reports - Your Universe Online A new combination therapy could cut treatment time for hepatitis C to just four weeks, but quicker recovery comes with a steep price, as the new medication is said to cost roughly $1,000 per pill. According to Reuters reporter Bill Berkrot, the treatment involves an experimental antiviral drug produced by Bristol-Myers Squibb and Sovaldi, a drug produced by Gilead Sciences Inc. that has reportedly outraged insurance companies and...

2014-06-18 12:29:54

Arrival of IFN-Free Therapies Will Bring Patients For Whom Current Therapies are Ineffective Back to the Drug-Treated Population, According to Findings from Decision Resources Group BURLINGTON, Mass., June 18, 2014 /PRNewswire/ -- Decision Resources Group finds that China's market for hepatitis C virus (HCV) drugs will be driven by an increase in its drug-treated population, following the introduction of novel HCV therapies. Nearly a third of patients diagnosed with HCV do not receive the...


Latest hepatitis C Reference Libraries

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (1 articles) »
Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related